课题基金 / 基金详情

IGF::OT::IGF Task Order 4 for Clinical Support for a phase 1 clinical interaction study between lorcaserin and cocaine POP: 08/18/2014 -08/17/2015.

IGF::OT::IGF Task Order 4 for Clinical Support for a phase 1 clinical interaction study between lorcaserin and cocaine POP: 08/18/2014 -08/17/2015.
IGF::OT::IGF 任务令 4，为氯卡色林和可卡因之间的 1 期临床相互作用研究提供临床支持 POP：08/18/2014 -08/17/2015。
批准号：
8951967
负责人：
DANIEL MOLINA
金额：
$55.49万
依托单位：
TECHNICAL RESOURCES INC
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
项目状态：
已结题
起止时间：
2014-03-19 至 2019-03-18
来源：
https://reporter.nih.gov/project-details/8951967
关键词：
ClinicalClinical PharmacologyClinical ResearchCocaineContractorContractsDataData ReportingDevelopmentDrug KineticsInvestigational DrugsLaboratory StudyMonitorPharmaceutical PreparationsPharmacodynamicsPhaseProcessProtocols documentationRegulationReportingResearch DesignResourcesSpecific qualifier valueUnited States Food and Drug Administrationdrug of abusemeetings

项目摘要

项目成果

DANIEL MOLINA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this contract is to provide pharmacokinetic resources in support of PK/PD studies. No actual clinical or laboratory studies will be carried out under this contract. The types of studies the contract will support include clinical pharmacology/pharmacokinetic studies and interaction studies between study medications and specified drugs of abuse.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 02/09/2025. NIDA REF. NO. N01DA-19-8947.
FY23. TO5. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 01/18/2022 - 04/16/2024. NIDA REF. NO. N01DA-19-8947.
NIAID CLINICAL DATA AND SAFETY MANAGEMENT CENTER (CDSMC)
DATA COORDINATING CENTER FOR SPROUTS AGES 6- AND 7- YEARS ASSESSMENTS AND STUDY CLOSEOUT
海外基金